Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 15;407(2):199-205.
doi: 10.1042/BJ20070408.

Domain mapping on the human metastasis regulator protein h-Prune reveals a C-terminal dimerization domain

Affiliations

Domain mapping on the human metastasis regulator protein h-Prune reveals a C-terminal dimerization domain

Sabine Middelhaufe et al. Biochem J. .

Abstract

The human orthologue of the Drosophila prune protein (h-Prune) is an interaction partner and regulator of the metastasis suppressor protein NM23-H1 (non-metastatic protein 23). Studies on a cellular breast-cancer model showed that inhibition of the cAMP-specific PDE (phosphodiesterase) activity of h-Prune lowered the incidence of metastasis formation, suggesting that inhibition of h-Prune could be a therapeutic approach towards metastatic tumours. H-Prune shows no sequence similarity with known mammalian PDEs, but instead appears to belong to the DHH (Asp-His-His) superfamily of phosphoesterases. In order to investigate the structure and molecular function of h-Prune, we expressed recombinant h-Prune in a bacterial system. Through sequence analysis and limited proteolysis, we identified domain boundaries and a potential coiled-coil region in a C-terminal cortexillin homology domain. We found that this C-terminal domain mediated h-Prune homodimerization, as well as its interaction with NM23-H1. The PDE catalytic domain of h-Prune was mapped to the N-terminus and shown to be active, even when present in a monomeric form. Our findings indicate that h-Prune is composed of two independent active sites and two interaction sites for the assembly of oligomeric signalling complexes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Domain architecture of h-Prune and protein fragments used in this study
(a) Domain arrangement in h-Prune. A well-defined DHH domain is followed by a less well-conserved DHHA2 domain and a C-terminal CHD with a putative coiled-coil region and a proline-rich region. The constructs of h-Prune and its fragments which were expressed and purified in this study are indicated. (b) Alignment of h-Prune (370–453) with the cortexillin I coiled-coil region. The best-aligned region of h-Prune covers the predicted coiled-coil in the N-terminal section of the CHD subdomain, and a secondary structure prediction for h-Prune is indicated on top of its sequence. (c) Limited proteolysis of full-length h-Prune at 4 °C and 25 °C respectively. The protease used is detailed on top, and the fragments which were further analysed are indicated on the right-hand side.
Figure 2
Figure 2. Mapping of dimerization and catalytic domains
(a) Behaviour of full-length h-Prune and of h-Prune (1–393) in size-exclusion experiments. A logarithmic graph of a molecular-mass standards (MW) and the elution volumes of these proteins is shown. At the elution positions of the two h-Prune constructs, labels indicate the molecular masses for a monomeric and a dimeric species respectively. (b) Comparison of specific activities of full-length h-Prune (□) and the monomeric h-Prune (1–393) construct (▲). Shown is a double reciprocal plot used for the determination of Km and Vmax values [fit for full-length h-Prune, solid line; h-Prune (1–393), dotted line]. Both proteins show almost identical activity despite their different oligomeric states.
Figure 3
Figure 3. Interaction of h-Prune with NM23-H1
Pull down experiments were performed using His-tagged and phosphorylated NM23-H1 and either full-length h-Prune or h-Prune (1–393). (a) Lane 1, molecular-mass standards. Lanes 2–5, pull down with full-length h-Prune: lane 2, flow-through; lane 3, first wash; lane 4, second wash; lane 5, elution. Lanes 6–9, pull down with h-Prune (1–393); lane allocation is the same as for lanes 2–5. (b) As a control for non-specific interactions, NM23-H1 was incubated with BSA. Lane 1, molecular-mass standards; lane 2, flow-through; lane 3, wash; lane 4, elution. (c) Pull down experiment with tagged full-length h-Prune (lanes 1–5). GSK3β binds h-Prune in the presence of excess NM23-H1, indicating a non-competitive interaction. Lanes 6–9: control, showing that there is no non-specific binding of GSK3β to the resin. Lane 1, molecular-mass standards; lanes 2 and 6, flow-through; lanes 3 and 7, first wash; lanes 4 and 8, second wash; lanes 5 and 9, elution.
Figure 4
Figure 4. Model for the architecture of h-Prune-containing complexes
Homodimers of h-Prune are created, containing two separate and independent catalytic cores formed by the DHH and DHHA2 subdomains (blue). They are held together through interactions with the C-terminal CHD (green), which consists of a putative coiled-coil region (left), a proline-rich region (centre), and a helical extension (right). The two CHDs of the dimer also enable the binding of at least two partner molecules, such as NM23-H1 (yellow) and GSK3β (red), which can lead to the assembly of higher-order oligomeric structures. The various parts of h-Prune, as well as its interaction partners, are not drawn to scale, and the exact binding sites for GSK3β and NM23-H1 within the CHD are not yet known.

Similar articles

Cited by

References

    1. Florenes V. A., Aamdal S., Myklebost O., Maelandsmo G. M., Bruland O. S., Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992;52:6088–6091. - PubMed
    1. Fan Z., Beresford P. J., Oh D. Y., Zhang D., Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 2003;112:659–672. - PubMed
    1. Steeg P. S. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer. 2003;3:55–63. - PubMed
    1. Radinsky R., Weisberg H. Z., Staroselsky A. N., Fidler I. J. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res. 1992;52:5808–5814. - PubMed
    1. Hartsough M. T., Steeg P. S. Nm23/nucleoside diphosphate kinase in human cancers. J. Bioenerg. Biomembr. 2000;32:301–308. - PubMed

Publication types